The comparison between FDG-PET and RECIST in detection and duration of response to RAD001 in patients with metastatic renal cell cancer (mRCC).
2010
e15077 Background: A phase II study assessing the activity of RAD001 (Afinitor) in patients with metastatic clear cell renal cell carcinoma has been published in Cancer, 2009 115(11). The purpose i...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI